Invest in Israeli Start-up

OmegaMore has developed an innovative and breakthrough biotechnology product that will help millions live a healthier life span and treat, curb and prevent chronic brain disorders!

Invest in Israeli Start-up

OmegaMore has developed an innovative and breakthrough biotechnology product that will help millions live a healthier life span and treat, curb and prevent chronic brain functions!

Groundbreaking development in a market valued over $30 billion!

OmegaMore is a biotech company that develops, manufactures and markets omega-3 fatty acids supplements. The company has developed a groundbreaking product based on an innovative formula with essential ingredients that many studies have shown are essential for prevention and coping with cognitive diseases such as Alzheimer's, depression and ADHD, as well as a wide range of heart, liver, and metastatic cancer.

The Need

  • Increasing demand for "functional food" - Food fortified with essential supplements is a market estimated in billions of dollars (34 billion as of 2017), and the need for "healthy" food consumption continues to rise.
  • Multiple chronic diseases - cardiovascular diseases, are one of the main causes of mortality in the Western world.
  • Insufficient DHA intake - According to many studies, omega-3 deficiency in general, and DHA in particular, is the main cause of brain function diseases and the formation of infections that cause heart disease.

The Solution

The product purpose is to improve the quality of life by preventing the development of most diseases of brain function, as well as cardiovascular diseases, and even alleviate the existing diseases by filling omega-3 deficiency fatty acids in the body. Studies had shown that the product also helps to prevent the development of ADHD among children, as well as to help the development of the fetus

  • A dietary supplement that according to studies significantly reduces heart and liver disease, reduces the risk of chronic diseases and helps pregnant women give birth to a healthier child.
  • An additive that is also accessible for people who can not take pills - in the form of oil or powder.
  • A supplement that is made from algae allows people who can not consume a supplement based on fish or krill (small crustaceans), such as vegans and vegetarians to consume it, this way we approach a market which is on the rise in the past years.

Technology

The main active ingredient in Omega 3 that helps prevent disease is called DHA.

  • Development, growth and cultivation of unique seaweeds in laboratories and in clean pools, a unique extraction process of DHA omega-3 at a concentration of 40-50% significantly higher than most competitors.
  • Algae are grown in freshwater ponds to which salts and minerals are added - in this way we mimic the natural environment of algae but avoid exposure to pollution and heavy metals that are present at sea.
  • Differences between omega-3 based on seaweed vs. fish/krill oil - fish/krill (tiny crustaceans) feed on algae to absorb omega-3s in their bodies, by producing omega-3 directly from the algae we cut “the middle man” and help fight overfishing.

Global Market Revenue

Market

Invest in a product based in a market valued over $30 billion!

  • Demand and consumption of quality additives in the global market are constantly rising.
  • As a result of the growth of the earth's population, the rise in the standard of living in countries such as India and China and the desire for longevity - the demand for functional food has increased.
  • In 2017, the market was valued at $ 34.8 billion, while in the US alone it was estimated at $ 2.04 billion.
  • Between 2015 and 2016, growth was estimated at $ 2 billion, and by 2025 the market is expected to double and reach $ 57 billion.
  • The main omega-3 extract in the market is based on fish oil, and makes up 83.5% of the market as of 2016.
  • The algae-based market is the fastest growing market in Omega 3

The Team

Israel Galmor

CEO and Founder

An experienced CEO with years of management experience, including Omegal which he founded. An expert in the field of omega-3 fatty acids and nutritional supplements, with over 20 years of experience in the food industry and chemical formula development in the largest companies in the field, including Teva.

Ofer Taran

VP Sales & Marketing

Ofer has 25 years of experience in managing international projects in marketing, business development, as well as in the development of private brands, and several start-ups in the field of pharma and bio-med, as well as in giant companies as manager of Orbotech in the UK, He was CEO of Biosan Medical, which he managed for 12 years.

Yossi Gabay

Chief Financial Officer

Yossi served as CEO and CFO of several companies, including CFO of Shomera Insurance Company for 10 years, and served as CEO of the “Shahar Hadash” group (a public company until recently) for 15 years

Adam Glamor

Technology and information security consultant

Adam is experienced software developer that worked in some of Israel’s largest high-tech companies such as Check Point and Radware. He manages the information systems that include inventory, suppliers and customers, as well as the security and protection of information.

The Team

An experienced CEO with years of management experience, including Omegal which he founded. An expert in the field of omega-3 fatty acids and nutritional supplements, with over 20 years of experience in the food industry and chemical formula development in the largest companies in the field, including Teva.

Israel Galmor
CEO and Founder

Ofer has 25 years of experience in managing international projects in marketing, business development, as well as in the development of private brands, and several start-ups in the field of pharma and bio-med, as well as in giant companies as manager of Orbotech in the UK, He was CEO of Biosan Medical, which he managed for 12 years.

Ofer Taran
VP Sales & Marketing

Yossi served as CEO and CFO of several companies, including CFO of Shomera Insurance Company for 10 years, and served as CEO of the "Shahar Hadash" group (a public company until recently) for 15 years

Yossi Gabay
Chief Financial Officer

Adam is experienced software developer that worked in some of Israel's largest high-tech companies such as Check Point and Radware. He manages the information systems that include inventory, suppliers and customers, as well as the security and protection of information.

Adam Glamor
Technology and information security consultant

How to Invest

Investment model with ExitValley

The investment in OmegaMore is fully and safely implemented through ExitValley, the largest mass investment platform in Israel.
ExitValley makes it possible to invest in innovative Israeli startups, become shareholders and be part of the next exit.
The company was founded by Yaron Adler, Yaniv Shiryon and Oded Federbush, one of Israel’s high-tech industry leaders.

Over the past year, more than 40 million NIS has been invested in a variety of white and blue start-ups.

Capital raising is underway!

Get in touch with the entrepreneurs!

OmegaMore’s venture offers a unique investment opportunity – Israeli development for a global need that may improve quality and life expectancy, it also represents a breakthrough in a growing market that generates billions of dollars a year.

If you want to take part in our revolutionary project, please leave details and contact us as soon as possible

  • Minimum investment starting at $ 6,000
  • The number of places in this amount is limited to the first week of the campaign

You can leave your details and one of the founders will contact you for a detailed explanation.